Combined Peri-operative Lapatinib and Trastuzumab in Early HER2 Positive Breast Cancer can Identify Early Responders: Results from the UK EPHOS-B Trial (CRUK/08/002
Date
2022-04-01Author
Bliss, J
Porta, N
Emson, M
Miller, S
Morden, J
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Clinical Trials & Statistics Unit
Language
eng
Date accepted
2021-12-20
License start date
2021-12-20
Citation
Clinical Cancer Research
Publisher
American Association for Cancer Research